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Kidney organoids have been produced from human pluripotent stem cells (hPSCs) by specific induction of the metanephric mesenchyme (MM) lineage (including nephron progeni-
tor cells, NPCs)1–7, or by the simultaneous induction of MM- and 
ureteric bud (UB)-like progenitors8,9, the two progenitor cell pop-
ulations that give rise to the adult kidney during development. 
Recently, NPCs and UB progenitors were separately induced and 
then aggregated together into three-dimensional (3D) spheroids 
that generated kidney organoids with higher-order architecture10. 
For kidney organoids generated from human embryonic stem cells 
(hESCs), CRISPR/Cas9 technology can be used to recapitulate the 
molecular features of kidney diseases4. Human kidney organoids 
can also be used as unprecedented in vitro models to screen for 
nephrotoxicity3,4,9. Besides the importance of these findings, major 
concerns related to the lack of vascularization and insufficient 
maturation still require further investigation to advance the field 
of hPSC-derived kidney organoids (kidney organoids). Biophysical 
cues have been shown to regulate cell behaviour, including the 
stemness and differentiation of different stem cell populations. 
Recently, application of fluid flow enhanced hPSC-derived podo-
cyte-like cell differentiation in monolayer culture11, and the modu-
lation of adherent forces in kidney organoids, resulted in changes in 
the functional performance of proximal tubular epithelial-like cells 
within kidney organoids12.

Efficient generation of kidney organoids in 3D culture
During mammalian kidney development, the posterior primitive 
streak (PPS) and anterior primitive streak (APS) give rise to the 
intermediate mesoderm (IM) and definitive endoderm, respectively. 
The posterior IM generates the MM, whereas the anterior IM forms 
the UB. The PPS can be generated from hPSCs using a combination 
of growth factors (including BMP4)1,7,8, or by exposing undiffer-
entiated cells to varying doses and durations of the Wnt signalling 
agonist CHIR99021 (CHIR), a widely used inhibitor of glycogen 
synthase kinase 3 (GSK3β )1–5,8,9. Building upon these observations, 
we asked whether PPS cells could be generated by exposing hPSCs 
to a high dose of CHIR (8 µ M) in two-dimensional monolayer cul-
ture over three consecutive days (Supplementary Fig. 1a; Methods). 
This treatment regimen was sufficient to induce PPS-committed 
cells that were positive for the PPS marker BRACHYURY (referred 
to as T), at 82.2 ± 2.6% efficiency (Supplementary Fig. 1b,c). PPS-
committed cells upregulated the expression of PPS genes in compar-
ison with APS genes (Supplementary Fig. 1d). Subsequent exposure 
of PPS-committed cells to a combination of FGF9 and activin A 
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The generation of organoids is one of the biggest scientific advances in regenerative medicine. Here, by lengthening the time 
that human pluripotent stem cells (hPSCs) were exposed to a three-dimensional microenvironment, and by applying defined 
renal inductive signals, we generated kidney organoids that transcriptomically matched second-trimester human fetal kidneys. 
We validated these results using ex vivo and in vitro assays that model renal development. Furthermore, we developed a trans-
plantation method that utilizes the chick chorioallantoic membrane. This approach created a soft in vivo microenvironment 
that promoted the growth and differentiation of implanted kidney organoids, as well as providing a vascular component. The 
stiffness of the in ovo chorioallantoic membrane microenvironment was recapitulated in vitro by fabricating compliant hydro-
gels. These biomaterials promoted the efficient generation of renal vesicles and nephron structures, demonstrating that a soft 
environment accelerates the differentiation of hPSC-derived kidney organoids.
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(20:1) for an additional day resulted in acquisition of the early IM 
marker PAX2 at 85.0 ± 1.4% efficiency (Supplementary Fig.  2a–c; 
Methods). Accordingly, messenger RNA levels for the posterior IM 
markers OSR1 and HOXD11 and the anterior IM marker GATA3 
were also upregulated at this stage (Supplementary Fig. 2d).
We next reasoned that increasing the time that IM-committed 
cells are exposed to 3D culture, which increase cell-to-cell and cell-
to-extracellular matrix interactions, would generate kidney organ-
oids at higher efficiencies than previously reported3,8,9. Therefore, 
3D spheroids were generated by the self-aggregation of IM cells and 
maintained under 3D organotypic culture until day 16 (Fig. 1a; see 
Methods). Treatment of IM-committed 3D spheroids (day 0) with 
CHIR (3 µ M) for 3 d (from day 0 to day 3), while maintaining FGF9 
signalling (from day 0 to day 7), resulted in the formation of numer-
ous renal vesicles (RVs) on day 8 (Supplementary Fig. 3a,b), which 
were analysed by immunofluorescence for RV-associated markers, 
including PAX2, WT1, LHX1, PAX8, HNF1β , ECAD and BRN1 
(Supplementary Fig. 3a,c,d). Remarkably, SIX2-positive cells were 
absent on day 8, indicating the lack of MM progenitors at this stage 
(Supplementary Fig. 3d). In addition, downregulation of the epithe-
lial-to-mesenchymal markers TWIST and SNAIL and upregulation 
of WNT4 and ECAD coincided with initiation of the mesenchy-
mal-to-epithelial transition, which is essential for nephrogenesis 
(Supplementary Fig. 3e). RV-stage organoids were then differentiated 
in the absence of growth factors (from day 7 to day 16). This resulted 
in the derivation of kidney organoids with multiple nephron-like 
structures that were segmented into typical nephron components, 
including proximal tubules (LTL+ AQP1+/SLC3A1+), loops of Henle 
(ECAD+ UMOD+), distal tubules (UMOD− ECAD+), and glomer-
uli (PODXL+/PODOCIN+/NEPHRIN+/NEPH1+/WT1+ PODXL+ 
LTL−/PODOCIN+ LTL−) (Fig.  1b, Supplementary Fig.  4a–g). 
In addition, quantitative PCR (qPCR) and immunofluorescence 
analyses confirmed that isolated LTL− and LTL+ cell fractions from 
day 16 organoids expressed markers of glomerular and proximal 
tubular identity, respectively (Supplementary Fig. 5a–f). Similarly, 
markers representative of the major steps of differentiation were 
analysed by qPCR (Supplementary Fig. 6). Our methodology was 
quite robust, as kidney organoids from two commercial hESClines 
and one human induced pluripotent stem cell (hiPSC) line were also 
generated (Supplementary Fig. 7a–d, Supplementary Fig. 8).
To gain insight into the sequence of transcription regulatory 
events necessary to promote renal differentiation from hPSCs, we 
performed RNA sequencing (RNA-Seq) analysis at major stages 
during the differentiation process. We compared our results with 
transcriptional data from human fetal organs/tissues from the 
first and second trimesters of gestation13,14 (Supplementary Fig. 9, 
Supplementary Table  1; Methods), demonstrating that our tech-
nique specifically generated renal lineages. Importantly, RNA-Seq 
analysis showed that day 8 RV-stage organoids transcriptionally 
matched human fetal kidneys at 16 weeks of gestation, whereas day 
16 kidney organoids matched human fetal kidneys at 22 weeks of 
gestation (Fig. 1c, Supplementary Table 2; Methods). We validated 
these findings by analysing markers of nephron progenitors (SIX2, 
SALL1, PAX2), the proximal tubular segment (SLC3A1) and the glo-
merular compartment (NPHS1, PODXL, SYNPO, WT1) via qPCR 
(Fig.  1d). Additionally, immunofluorescence analysis showed that 
localization of late-stage nephron markers was comparable between 
kidney organoids and human fetal kidney samples (Supplementary 
Fig. 4a–g). Transmission electron microscopy (TEM) analysis was 
performed on day 16 kidney organoids (Fig. 1e–j). Ultrathin sec-
tions revealed the presence of primitive podocyte-like cells with 
deposition of a basement membrane (Fig. 1g) and developing pri-
mary and secondary cell processes (Fig. 1h). Epithelial tubular-like 
cells with brush borders and high mitochondrial content were also 
detected (Fig. 1i,j).
Kidney organoids recapitulate human kidney development
The formation of kidney organoids with segmented nephrons may 
depend on the existence of a transient population of NPCs respon-
sible for the generation of nephron structures in vitro. We analysed 
by immunofluorescence the expression of OSR1, WT1, PAX2 and 
SIX2, confirming that cells exhibiting a NPC signature were pres-
ent in day 5 spheroids (Supplementary Fig. 10a,b). The posterior 
origin of NPCs was also confirmed by the detection of HOXD11, 
OSR1, and WT1 mRNA by qPCR (Supplementary Fig.  10c). 
Interestingly, the anterior IM fate was also generated at this stage, 
as GATA3 mRNA was detected (Supplementary Fig.  10c). We 
next evaluated the ability of day 5 NPCs to form kidney chimae-
ric structures ex vivo, taking advantage of a faithful reaggregation 
assay with mouse embryonic kidney cells15,16. After 6 d of culture, 
differentiated NPCs, identified by the expression of human nuclear 
antigen (HuNu), integrated into nascent nephron structures 
that expressed WT1 in the glomerular segment and PAX8 in the 
nascent nephron (Fig. 2a–f; Methods). Thus, day 5 NPCs exhibited 
the capacity to integrate into mouse nascent nephron structures, 
but not into the UB compartment, suggesting that the induction of 
UB derivatives from hPSCs may depend on additional exogenous 
signals. These results challenge previous findings9 and agreed with 
a recent study that identified optimal time windows and exogenous 
signals for selectively inducing NPC and UB lineages from mouse 
and human PSCs10.
Next, we investigated the capacity of human kidney organoids 
to faithfully recapitulate complex nephron patterning events that 
have been mainly studied in the mouse model17. Day 8 RV-stage 
organoids were exposed to inhibitors of tankynase (IWR1) and 
GSK3β (CHIR) to decrease or increase β -catenin signalling, respec-
tively. CHIR treatment reduced the number of WT1+ glomerulus-
like structures when compared with vehicle (control) and IWR1. In 
contrast, the percentage of LTL+ proximal tubule-like structures was 
unchanged (Fig. 2g,h). qPCR analysis confirmed a decrease in the 
expression of WT1 and PODXL (proximal segment), and the induc-
tion of WNT4 (a β -catenin target gene) in CHIR-treated organ-
oids relative to control, whereas PAX2 (whole nephron) remained 
unchanged (Fig.  2i). We next determined the effect of disrupting 
Notch signalling by treating day 8 RV-stage organoids with the 
γ -secretase inhibitor DAPT. Inhibition of Notch resulted in a severe 
loss of proximal tubule-like structures (LTL+), together with a 
reduction in PODXL+ glomerulus-like structures when compared 
with control (Supplementary Fig. 11a,b). qPCR analysis confirmed 
the downregulation of proximal (WT1) and medial (SLC3A1) 
nephron segment markers (Supplementary Fig.  11c). These find-
ings agree with the role of Notch signalling in specifying proximal 
and medial identity during nephron patterning in the mouse17, and 
expand previous knowledge about the effect of Notch signalling on 
kidney organoids3.
The kidney is a highly metabolic organ that generates ATP 
through oxidative phosphorylation. Into the light of this knowl-
edge, we hypothesized that the energy metabolism profile of cells 
should be taken into account to promote the differentiation of 
hPSCs into renal subtypes. Therefore, we exposed day 8 RV-stage 
organoids to either cell culture medium that promotes glycolysis 
in stem cells18 (endothelial cell growth medium, EGM) or cell cul-
ture medium favouring oxidative phosphorylation (renal growth 
medium (REGM) with insulin) for 8 d. Seahorse analysis revealed 
that REGM increased mitochondrial respiration in kidney organ-
oids when compared with EGM (Fig. 2j–l), promoting an oxida-
tive phosphorylation bioenergetic phenotype. Kidney organoids 
under REGM conditions enhanced tubule differentiation, as 
shown by the development of prominent proximal tubular struc-
tures (LTL+), more than with EGM (Fig. 2m,n), in agreement with 
previous findings19.
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Fig. 1 | Efficient generation of kidney organoids in 3D culture. a, Schematic of the stepwise differentiation methodology for generating kidney organoids 
from hPSCs. b, Confocal microscopy images of glomerular structures in day 16 kidney organoids showing podocyte-like cells positive for PODXL, nephrin, 
NEPH1 and podocin, and the basement membrane protein laminin. Scale bars, 25 µ m. c, Dendrogram representing the hierarchical clustering of day 0,5,8 
and 16 kidney organoids with human fetal kidneys from 9, 13, 17 and 18 weeks of gestation (first trimester) and 22 weeks of gestation (second trimester). 
Data from Chuva de Sousa Lopes (SRP055513)13 (1) and McMahon (SRP111183)14 (2) are included in the analysis. d, qPCR analysis during kidney organoid 
differentiation and 13-, 16-, and 22-week human fetal kidneys (genes are indicated). Data are mean ±  s.d. For SIX2, WT1, SALL1 and PAX2, day 0, day 5, 
n =  3; day 8, day 16, n =  2. For PODXL, SLC3A1, SYNPO and NPHS1, day 0, day 5, n =  1; day 8, day 16, n =  2. Each sample is a pool of six organoids. Three 
technical replicates are shown per sample. e,f, Semithin sections of day 16 kidney organoids showing glomerular (e) and tubular-like (f) structures. Scale 
bars, 100 µ m. g–j, TEM of day 16 kidney organoids. g, Immature podocytes. Scale bar, 5 µ m. h, A magnified view of the boxed region in g showing a detail of 
podocyte-related structures including the deposition of a basement membrane (bm), and primary (pp) and secondary cell processes (sp). Scale bar, 1 µ m. 
i, Epithelial tubular-like cells with brush borders (bb), high mitochondrial (mit) content and tight junctions (tj). Scale bar, 2 µ m. j, A magnified view of the 
boxed region in i showing a detail of brush borders. Scale bar, 1 µ m.
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Fig. 2 | Kidney organoids model human kidney organogenesis in vitro. a, Representation of the coculture of day 5 NPCs with mouse embryonic kidney 
cells. b–d, Bright-field images of reaggregates after 1 d (b), 4 d (c) and 6 d (d) in culture. Scale bars, 500 µ m. e, Immunocytochemistry for PAX8, WT1 and 
HuNu of the reaggregate in d. Scale bar, 250 µ m. f, Magnified views of d. Scale bars, 50 µ m. g–i, Modulation of β -catenin signalling in kidney organoids 
with IWR1 and CHIR inhibitors. g, Immunocytochemistry for WT1 and LTL in day 16 kidney organoids with the indicated regimens. Scale bars, 50 µ 
m. h, Corresponding quantification of the percentage of WT1+ cells and LTL+ structures. Data are mean ±  s.d. n =  3 organoids per treatment. One-way 
analysis of variance with Tukey´s post hoc test. For % WT1, F (1.009, 2.017) =  213.6, P =  0.0045; vehicle versus CHIR, **P =  0.0082; CHIR versus IWR1, 
****P =  0.000034; vehicle versus IWR1, n.s., not significant, P =  0.9995. For % LTL, F (1.002, 2.004) =  0.9976, P =  0.4232, not significant. i, Corresponding 
qPCR analysis (genes are indicated). Data are mean ±  s.d. (three technical replicates). j–l, Energy metabolism profile of kidney organoids maintained in 
EGM or REGM: kinetic oxygen consumption rate (OCR) response (


j), inner mitochondrial membrane proton leak and cellular ATP production (k) and basal 
respiration and spare respiratory capacity (l). Data are normalized to mitochondrial DNA copy number/sample. Data are mean ±  s.d. n =  3 (EGM) and n =  2 
(REGM) organoids. m, Immunocytochemistry for LTL and PODXL in day 16 kidney organoids under EGM or REGM regimen. Scale bars, 200 µ m (EGM) and 
400 µ m (REGM). n, Corresponding quantification of the percentage of PODXL+ and LTL+ structures. Data are mean ±  s.d. n =  2 organoids per condition.
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Vascularization of kidney organoids using chick 
chorioallantoic membrane (CAM)
Kidney organoids have shown the presence of nascent vascular 
endothelial cells surrounding renal structures, but lack a proper 
vascular pattern4,9. Of note, only two independent studies have 
reported in vivo vascularization of either hiPSC-derived NPCs20 
or kidney organoids21 when transplanted under the kidney capsule 
of immunodeficient mice, identifying in both cases host-derived 
vascularization. We decided to explore an alternative approach for 
providing a vascular environment to kidney organoids. We made 
use of the chick CAM, a highly vascularized extraembryonic tis-
sue that has been used in tumour angiogenesis research22,23 and for 
the grafting of biomaterials24. More so than other in vivo models, 
such as the mouse, CAM represents a naturally immunodeficient 
environment that offers direct, minimally invasive access to the 
assay site, thereby facilitating the monitoring of the experiments 
in situ. We implanted day 16 kidney organoids into the CAM of 
7-day-old chick embryos, and then maintained them in ovo for 5 d 
(Fig. 3a; Methods). On day 3 of implantation, multiple blood ves-
sels from the CAM were macroscopically distinguished throughout 
kidney organoids (Fig. 3b, Supplementary Video 1). The circulation 
of chick blood within kidney organoids was clearly observed after 
5 d (Fig.  3c, Supplementary Video  2). At this stage, in vivo injec-
tion of dextran–FITC (fluorescein isothiocyanate) into the CAM 
allowed for live imaging of the vasculature, confirming the grafting 
of the organoids into the CAM (Fig. 3d, Supplementary Video 3). 
Compared with in vitro counterparts (Supplementary Fig.  12a), 
CAM-implanted kidney organoids (implanted organoids) exhibited 
glomeruli with an enlarged Bowman’s space and tubule-like struc-
tures with enlarged lumens (Supplementary Fig. 12b,c, magnified 
views). Furthermore, CAM blood vessels (indicated with asterisks 
in Supplementary Fig. 12b,c,d) were found in close vicinity to glom-
erulus structures. Immunofluorescence analysis of consecutive sec-
tions confirmed the presence of chick blood vessels (labelled with 
Lens culinaris agglutinin) within implanted organoids. The latter 
were identified by the expression of the human marker HuNu and 
the presence of glomerulus-like structures (WT1+) (Supplementary 
Fig.  12e). Next, we tested the ability of implanted organoids to 
respond to the well known nephrotoxic agent cisplatin. Twenty-four 
hours after injecting cisplatin into the chick vasculature, levels of 
KIM-1 (a marker of renal tubule toxicity) and cleaved CASPASE 3 
(a classical apoptotic marker) were upregulated in proximal tubular 
structures (LTL+), compared with specimens injected with a control 
solution (Supplementary Fig. 12f,g).
We next analysed semithin (Fig.  3e) and ultrathin sections 
(Fig. 3f–k) of implanted organoids. TEM images revealed the pres-
ence of aligned podocyte-like cells on one side of a linear base-
ment membrane (Fig. 3f–h). Endothelial-like cells were found on 
the opposite side of the basal lamina (Fig.  3f) and, occasionally, 
chicken erythrocytes were observed within the glomerular-like 
structures (Fig. 3h). Podocyte-like cells exhibited multiple micro-
villi on the apical surface and extended primary and secondary cell 
processes on the basal side (Fig.  3f–i, Supplementary Fig.  12h–j). 
Secondary cell processes were bridged by slit diaphragm-like struc-
tures (Fig. 3g–i, Supplementary Fig. 12h–j). These features, which 
reflect functional differentiation, were not detected in the organoids 
cultured in vitro (Fig. 1g, h). Furthermore, tubular-like cells with 
thick brush borders and high mitochondrial content were observed 
(Fig. 3j,k). Immunofluorescence analysis showed apical localization 
of PODXL in aligned podocyte-like cells situated on the basement 
membrane (LAMININ+). Conversely, podocin and NEPH1 local-
ized on the podocyte basal side (Fig. 3l). Likewise, CD34+ endothe-
lial-like cells (stained with an antihuman specific CD34 antibody) 
were closely associated with NEPHRIN+/PODXL+ podocyte-like 
cells within glomerulus-like structures in implanted organoids 
(Fig. 3m, Supplementary Fig. 12k). Moreover, endothelial-like cells 
(CD31+) within glomerulus-like structures (PODXL+) coexpressed 
the human marker HuNu (Fig. 3n). In contrast, for kidney organ-
oids cultured in vitro, CD34+ endothelial-like cells were not found 
within glomerulus-like structures (PODXL+) (Supplementary 
Fig. 12l).
soft hydrogels enhance the formation of kidney organoids
Mirroring the exact biochemical (for example, site-specific bioactive 
ligands) and biophysical (for example, extracellular matrix stiffness, 
fluid flow, oxygen tension) properties of a physiological environ-
ment represents an as yet unaffordable technical approach in tissue 
engineering. By contrast, fabrication of hydrogels with mechanical 
properties (for example, Young’s modulus) similar to native tissues 
is a key methodology for guiding cellular responses and differentia-
tion25. Therefore, we decided to characterize the specific mechani-
cal properties of the CAM (by measuring the Young’s modulus, 
Supplementary Fig. 13a; Methods), which exhibited a stiffness value 
of about 1 kPa (Supplementary Fig. 13b), representative of an early 
embryonic microenvironment26 in which undifferentiated cells 
are primed for lineage commitment27. We next explored whether 
substrates mimicking a soft microenvironment may favour the 
generation of kidney organoids, compared with stiffer substrates. 
Thus, we fabricated functionalized polyacrylamide hydrogels of 
tunable stiffness (ranging from soft, 1 kPa, to very rigid, 60 kPa) 
as substrates for hPSC differentiation (Supplementary Fig.  14a; 
Methods). In comparison with rigid hydrogels, hPSCs grown on 
soft hydrogels under undifferentiated conditions formed tightly 
compacted hPSC colonies (ECAD+) (Supplementary Fig.  14b), 
showing reduced nuclear localization of the mechanotransduction 
marker Yes-associated protein (YAP) (Supplementary Fig.  14c). 
RNA-Seq analysis of hPSCs revealed that soft hydrogels promoted 
the expression of genes related to embryo and mesodermal differ-
entiation (Supplementary Table  3), suggesting that a soft milieu 
may better replicate early stages of embryonic development, dur-
ing which time counteracting gene regulatory networks control 
both pluripotency and differentiation ground states28. Based on 
these observations, we hypothesized that using soft hydrogels dur-
ing the first steps of monolayer differentiation (including PPS and 
IM induction) may help guide hPSCs toward renal commitment. 
PPS induction of hPSCs differentiated on soft hydrogels resulted 
in higher mRNA levels of T and SALL1 markers when compared 
with rigid conditions (Supplementary Fig.  15a,b). PPS differen-
tiation was also analysed by RNA-Seq, showing that soft hydrogels 
induced the expression of genes related to transcription regula-
tion and downregulated genes related to extracellular matrix and 
basement membrane (Supplementary Table  4, Supplementary 
Fig.  15c). Induction of PPS-committed cells into IM-committed 
cells (Supplementary Fig. 16a) showed that soft hydrogels promoted 
increased mRNA levels of the early IM marker PAX2, the posterior 
IM marker HOXD11, the anterior IM marker LHX1, and SALL1 
when compared with rigid conditions (Supplementary Fig.  16b). 
Upon differentiation under 3D organotypic culture, IM-committed 
cells derived on soft hydrogels began to develop RVs one day earlier 
(at day 7: Supplementary Fig. 16c), and resulted in the generation of 
more RVs than those derived on rigid hydrogels, as shown by quan-
titative analysis of PAX2+ RVs (Fig. 4a,b). Moreover, day 16 kidney 
organoids from soft conditions developed more WT1+ glomerulus-
like and LTL+ tubule-like structures than those derived from rigid 
conditions (Fig. 4c,d), and expressed increased mRNA levels of late-
stage nephron (NPHS1, SCNN1B) and vascularization (ENDOGLIN, 
VEGFR) markers (Fig. 4e). TEM of day 16 kidney organoids showed 
the presence of tubule-like structures containing epithelial cells with 
prominent brush borders in both soft and rigid conditions (Fig. 4f, 
Supplementary Fig.  17). Interestingly, soft hydrogels induced the 
differentiation of podocyte-like cells containing slit diaphragm-
like structures between the cell processes (Fig.  4g–i), a podocyte 
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Fig. 3 | In vivo vascularization of kidney organoids using chick CAM. a, Methodology for the implantation of day 16 kidney organoids into chick CAM.  
b,c, Macroscopic views of implanted organoids maintained in ovo for 3 d (b) and 5 d (c). d, The implanted organoid in c after intravital injection of dextran–
FITC through the chick vasculature. Scale bars, 1000 µ m (c,d). e, Semithin sections of a kidney organoid (dashed line) implanted in the CAM mesenchyme 
(m) for 5 d. Magnified views of glomerular (G) and tubular (T) cells are shown. Scale bars, 200 µ m, 100 µ m (magnified views). f–k, TEM of implanted 
organoids. Magnified views of the boxed regions in f,h,j are shown in g,i,k, respectively). f, Differentiated podocytes (p) extending primary cell processes 


(pp) and apical microvilli (black triangles) are located on one side of the basement membrane 


(bm) and a vascular endothelial cell (end) is found on the 
opposite side. g, Slit diaphragm-like structures (red arrows) between secondary cell processes (sp). h, Aligned podocytes showing primary cell processes 
and apical microvilli. er, chicken erythrocytes. i, A detail of the basement membrane and a slit diaphragm-like structure. j, Tubular-like cells. k, A detail of 
brush borders (bb). Scale bars, 2 µ m (f), 500 nm (g), 10 µ m (h), 2 µ m (i), 5 µ m (j), 1 µ m (k). l–n, Confocal microscopy images of glomerular structures in 
implanted organoids. l, Immunohistochemistry for PODXL, nephrin, NEPH1, podocin and laminin. Scale bars, 25 µ m. m, Immunohistochemistry for nephrin 
and CD34. Scale bars, 25 µ m, 10 µ m (magnified view). n, Immunohistochemistry for PODXL, CD31 and the human marker HuNu. Scale bars, 10 µ m, 5 µ m 
(magnified view). White arrows indicate endothelial-like cells in close contact with podocyte-like cells (m,n).
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Fig. 4 | soft hydrogels accelerate the differentiation of kidney organoids. a, Immunocytochemistry for PAX2 in RV-stage organoids generated using 1 kPa 
or 60 kPa hydrogels. Scale bars, 500 µ m, 150 µ m (magnified views). b, Quantification of a. The mean number of RVs and area percentage occupied by RVs 
were quantified. Data are mean ±  s.d. n =  2 organoids per condition. c, Immunohistochemistry for LTL, WT1 and ECAD in day 16 kidney organoids from 
1 kPa or 60 kPa. Scale bars, 500 µ m and 50 µ m (magnified views). d, Quantification of c. The percentages of WT1+ and LTL+ area were quantified. Data 
are mean ±  s.d. n =  3 organoids per condition. For WT1+, t(4) =  5.8057, **P =  0.0044. For LTL+, t(4) =  4.6023, *P =  0.0100. Two-tailed Student’s t-test. e, 
qPCR analysis of day 16 kidney organoids from 1 kPa or 60 kPa (genes are indicated). Data are mean ±  s.d. (technical replicates). f–i, TEM of day 16 kidney 
organoids from 1 kPa. f, Epithelial tubular-like cells with brush borders (bb). g, Podocyte-like cells with primary cell processes (pp). h,i, Magnified views of 
g. Secondary cell processes (black arrows) with slit diaphragm-like structures (red arrows). Red asterisks, podocyte membrane protrusions. bm, basement 
membrane. Scale bars, 2 µ m (f), 5 µ m (g), 500 nm (h), 200 nm (i). j, Day 16 kidney organoids from 1 kPa were implanted into the CAM.  
k–n, TEM of implanted kidney organoids from 1 kPa. k, Tubular-like cells with brush borders. l, Aligned podocyte-like cells extending primary cell processes 
near endothelial (en) cells and chicken erythrocytes (er). m,n, Magnified views of l. Secondary cell processes with slit diaphragm-like structures. Scale 
bars, 2 µ m (k), 10 µ m (l), 1 µ m (m), 200 nm (n).
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differentiation feature that was absent in rigid conditions (Fig. 1g,h, 
Supplementary Fig. 17). Considering these findings, day 16 kidney 
organoids derived from soft hydrogels were then implanted into 
the CAM for 5 days (Fig. 4j). TEM revealed the presence of tubu-
lar epithelial-like cells with brush borders (Fig. 4k) and numerous 
glomerular structures containing podocyte-like cells above a dense 
basement membrane and in close vicinity to endothelial cells and 
chicken erythrocytes (Fig. 4l). Furthermore, induced podocyte-like 
cells exhibited secondary cell processes with slit diaphragm-like 
structures (Fig. 4m,n).
Outlook
The methodology described here reduced the time needed to gen-
erate kidney organoids when compared with previous protocols 
by about 30%1,3–5,9, leading to the generation of kidney organoids 
that transcriptionally resembled second-trimester human fetal 
kidneys. This is an improvement over previous findings, in which 
kidney organoids clustered with trimester 1 human fetal kid-
neys9. Furthermore, here we have shown that kidney organoids 
implanted into chick CAM successfully engrafted and were vas-
cularized in ovo, providing a straightforward model for nephro-
toxicity and kidney disease modelling applications. Importantly, 
CAM-implanted kidney organoids showed morphological features 
that reflect functional differentiation compared with in vitro con-
ditions. When CAM stiffness was mimicked in vitro via compli-
ant hydrogels, hPSCs differentiated on soft substrates (CAM-like) 
generated IM-committed cells that showed an accelerated forma-
tion of more RVs and nephron structures than those produced on 
rigid substrates. Furthermore, kidney organoids generated from 
soft hydrogels exhibited improved differentiation characteristics 
when compared with those found under stiffer conditions. These 
differentiation features were also enhanced after CAM transplanta-
tion. Overall, the methodology described here paves the way toward 
further developing biomimetic approaches that will enhance organ-
oid differentiation (either in vitro or in vivo). These advances will 
enable future studies of kidney development and disease.
Online content
Any methods, additional references, Nature Research reporting 
summaries, source data, statements of data availability and asso-
ciated accession codes are available at https://doi.org/10.1038/
s41563-019-0287-6.
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Culture of hPSCs. All hPSC lines were obtained after the approval of the 
Ethics Committee of the Center of Regenerative Medicine in Barcelona and 
the Comisión de Seguimiento y Control de la Donación de Células y Tejidos 
Humanos del Instituto de Salud Carlos III (project numbers: 0336E/7564/2016; 
0336E/5311/2015; 0336E/15986/2016; 0336E/79489/2015; 00336E/20031/2014). 
ES[4] hESC and CBiPSsv-4F-40 were obtained from The National Bank of Stem 
Cells (ISCIII, Madrid). H1 and H9 hESC lines were purchased at Wicell. All the 
lines were maintained in Essential 8 medium (A1517001, Life Technologies) in cell 
culture plates coated with 5 µ g ml−1 vitronectin (A14700, Fisher Scientific) with 
5% CO2 at 37 °C. Cells were passaged every 4–6 d.
hPSC differentiation into renal progenitor cells and generation of 3D kidney 
organoids. hPSCs grown on vitronectin-coated plates were rinsed twice with 
PBS (1001–015, Life Technologies) and disaggregated into small cell clusters 
with 0.5 mM EDTA (E9884, Sigma). Cells were then seeded onto vitronectin-
coated culture plates at a density of 5 × 104–1.5 × 104 cells per cm2 in Essential 8 
medium (day − 5). After overnight culture, the differentiation was initiated by 
treating hPSCs with 8 µ M CHIR (SML1046, Sigma) in advanced RPMI 1640 basal 
medium (12633-012, Life Technologies) supplemented with 2 mM L-GlutaMAX 
(35050–038, Life Technologies) and penicillin/streptomycin (penicillin 
10,000 U ml−1:streptomycin 10,000 μ g ml−1; 15140122, Life Technologies) for 3 d 
(from day − 4 to day − 1). Next, cultures were treated with 200 ng ml−1 FGF9 (100–
23B, Peprotech), 1 µ ml−1 heparin (H3149-10KU, Sigma) and 10 ng ml−1 activin A 
(338-AC-050, Vitro) for 1 d (from day − 1 to day 0). Media changes were performed 
every day. On day 0, single-cell suspensions were obtained by dissociating cells 
with Accumax (07921, Stem Cell Technologies). Cells were then resuspended in 
advanced RPMI 1640 basal medium containing 3 μ M CHIR, 200 ng ml−1 FGF9 
and 1 µ g ml−1 heparin, placed in 96-well plates (V bottom) at 5 × 105 cells per well, 
spun down (300 g for 3 min) and maintained in culture for 2 d without medium 
change. On day 2, cell spheroids were placed onto Transwells (CLS3460, Sigma) 
and cultured in advanced RPMI 1640 basal medium containing 3 μ M CHIR, 
200 ng ml−1 FGF9 and 1 µ g ml−1 heparin for another 1 d. On day 3, CHIR was 
removed and organoids were maintained in advanced RPMI 1640 basal medium 
with 200 ng ml−1 FGF9 and 1 µ g ml−1 heparin for another 4 d. From day 7 organoids 
were maintained in advanced RPMI 1640 basal medium until day 16 unless 
otherwise indicated, changing the medium every second day.
Immunocytochemistry. After a single wash with PBS, samples were fixed with 4% 
paraformaldehyde (153799, Aname) for 20 min at room temperature. Next, samples 
were washed twice with PBS and further blocked using 


Tris-buffered saline (TBS) 
with 6% donkey serum (S30, Millipore) and 1% Triton X-100 (T8787, Sigma) for 
1 h at room temperature. Samples were then treated overnight at 4 °C with primary 
antibodies diluted in antibody dilution buffer consisting of TBS with 6% donkey 
serum and 0.5% Triton X-100. After three rinses with antibody dilution buffer, 
samples were treated for 4 h at room temperature with fluorescent-conjugated 
secondary antibodies (Alexa Fluor (A) 488-, Cy3- or A647-; 1:200). A previous 
blocking step with a streptavidin/biotin blocking kit (SP-2002, Vector Labs) was 
performed when samples were assayed for biotinylated LTL (B-1325, Vector Labs) 
and Alexa Fluor 488-conjugated streptavidin (SA5488, Vector Labs) was used to 
detect LTL+ cells. Nuclei were detected using 4,6-diamidino-2-phenylindole (DAPI; 
1:5000, D1306, Life Technologies) for 30 min. For mounting, samples were immersed 
in Fluoromount-G (0100-01, Southern Biotech). Image acquisition was carried out 
using an SP5 Leica microscope or a Zeiss LSM780 confocal microscope. Primary 
antibodies and associated information are provided in Supplementary Table 5.
Electron microscopy. After fixation of samples with 2.5% glutaraldehyde 
containing 1% tannic acid in 0.1 M phosphate buffer (pH 7.4), samples were 
postfixed for 1 h at 4 °C with 1% OsO4 in 0.1 M phosphate buffer. Graded ethanol 
series were performed followed by epoxy resin embedding. Toluidine blue staining 
was performed in semithin sections before examination using a light microscope. 
Then, ultrathin sections were obtained using an EM UC7 ultramicrotome (Leica 
Microsystems) and collected on copper grids. 4% uranyl acetate and lead citrate 
were then used for staining. Samples were subsequently analysed with a JEM 1230 
electron microscope (JEOL).
Total RNA isolation and qPCR with reverse transcription. TRI Reagent 
was employed for total RNA purification following the manufacturer’s 
recommendations (T9424, Sigma). TURBO DNase inhibitor (AM1907, Ambion) 
was used in order to eliminate any residual genomic DNA. Complementary DNA 
was synthesized from 1 µ g of RNA using a Cloned AMV First-Strand cDNA 
synthesis kit (12328, Invitrogen). Quantitative PCR with reverse transcription 
(QUANTSTUDIO 5 Applied Biosystems, Thermo Fisher Scientific) was used 
to quantify gene expression from cDNAs (25 ng/well) using PowerUp Sybr 
Green Master Mix (A25742, Thermo Fisher Scientific). GAPDH or Rplp0 were 
used for data normalization. Primer sequences used in this study are listed in 
Supplementary Table 6.
Next-generation RNA sequencing. Sequencing libraries were prepared from 1 µ 
g of total RNA (previously isolated using TRI Reagent—T9424, Sigma) using an 
Q8
Illumina TruSeq RNA Sample Prep Kit (catalogue no. FC-122–1001). Sequencing 
was carried out to produce between 50 and 60 million paired end reads/sample 
using the Illumina Hiseq 2500 platform. Raw sequences were inspected for their 
quality using FastQC (version v0.11.5)29 and trimmed using Skewer (version 
0.2.2)30. STAR mapper (version 2.5.3a)31 was used to align the data to the human 
reference genome (GRCh38). The option ‘–quantMode’ was employed to count the 
number of mapped tags within genes (annotation Gencode v26). On average, 90% 
of tags were univocally mapped either to the genomic or to a splice junction. Data 
from Chuva de Sousa Lopes (SRP055513)13 were analysed in the same way. Read 
counts per genes were finally analysed using the R statistical package DESeq232. 
Since the two experiments were performed using different techniques (RNA-Seq 
and DeepSAGE), we used the ComBat function from the svaseq R package33 on 
rlog-transformed read counts in order to mitigate the batch effect. Scaled rlog 
values were then used to calculate the sample-to-sample distance and plotted 
as a dendrogram. Data from Little (SRP059518)9 and McMahon (SRP111183)14 
were analysed using the same procedure. The package Keygenes13 was used to 
classify every sample according to its similarity to a tissue. Keygenes compares the 
transcriptional profiles of test samples with that from organs or cell types from 
a training set. In this study, the ‘fetal wo’ training set was used. This training set 
contains transcriptional data from17 fetal organs.
Flow cytometry. Cells were dissociated using Accumax (07921, Stem Cell 
Technologies) for 5 min at 37 °C. Next, cells were resuspended in PBS and 
incubated with LIVE/DEAD Fixable Violet stain reagent (L23105, Life 
Technologies) (1:1000) for 30 min in the dark. For intracellular staining, a Foxp3/
Transcription Factor Staining Buffer Set (00–5523–00, Labclinics) was used 
according to manufacturer’s instructions. Briefly, cell suspensions were fixed in 
the dark for 30–60 min at room temperature with Foxp3 fixation/permeabilization 
working solution. Permeabilization of samples was performed using the 




fetal bovine serum for 15 min. Incubations with conjugated antibodies 
were performed for 30 min. The antibodies used were OCT4 conjugated to Alexa 
Fluor 488 (560253, BD Pharmigen), brachyury conjugated to allophycocyanin 
(IC2085A, R&D Systems) and PAX2 (AF3364, R&D Systems) conjugated to A488 
using a Lightning-Link® Rapid conjugation kit (322–0010, Innova Biosciences) 
following the manufacturer’s instructions. Samples were then washed with 
permeabilization buffer and resuspended in PBS + 2% fetal bovine serum. 
For cell sorting experiments, kidney organoids were stained with fluorescein-
conjugated LTL (FL-1321, Vector Laboratories) as described elsewhere12. Kidney 
organoids were then dissociated to single cells using Accumax (07921, Stem Cell 
Technologies) for 15 min followed by 0.25% (wt/vol) trypsin (25300–054, Life 
Technologies) for 15 min at 37 °C. SA3800 software version 2.0.4 (SONY) was 
used to acquire flow cytometry samples in the Sony SA3800 spectral cell analyser 
(SONY). FACSDiva software version 8.0.1 (BD Biosciences) was used in the FACS 
Aria Fusion instrument (BD Biosciences) for cell sorting experiments. FlowJo 
software version 10 was used to analyse the data.
Reaggregation of mouse embryonic kidney cells with hPSC-derived NPCs. 
These experiments were performed following approval by the Ethics Committee on 
Animal Research of the University of Barcelona, Spain (protocol no. OB 391/18). 
Reaggregation experiments were carried out as previously described in ref. 16. In 
brief, embryonic kidneys from 11.5–12.5 d post conception were collected from 
time-mated pregnant C57BL/6J mice. Kidney rudiments were removed from 
mouse embryos by manual dissection under a dissecting microscope. Dissociation 
of kidney rudiments into single cells was performed by incubating kidneys with 
0.25% (wt/vol) trypsin (25300–054, Life Technologies) for 1–2 min at 37 °C, 
followed by quenching of trypsin using complete medium (MEM + 10% fetal 
bovine serum + penicillin/streptomycin) and pipetting up and down vigorously 
for 30 s to disaggregate kidneys. Day 5 organoids were dissociated into single cells 
with Accumax (07921, Stem Cell Technologies). The resultant cell suspensions 
were sieved through a 40 μ m pore cell strainer. Next, 7.2 × 105 mouse kidney cells 
were combined with 8 × 103 cells from day 5 organoids, placed in a 96-well plate 
(V bottom) in complete medium with 10 μ M ROCK inhibitor (72304, Stem Cell 
Technologies), spun down (300 g for 3 min) and incubated at 37 °C, 5% CO2 to 
allow aggregate formation. After overnight culture, aggregates were placed onto 
Transwells (CLS3460, Sigma) and maintained in complete medium at 37 °C and 
5% CO2 for 4–6 d. Medium changes were performed every 48 h.
Nephron patterning assays. For nephron patterning assays, samples were 
cultured in basic differentiation media supplemented with 10 μ M DAPT (565770, 
Sigma), 3 µ M CHIR (SML1046, Sigma) or 5 µ M IWR1 (681669, Sigma) from 
day 8 to day 16. Organoids were then collected for RNA isolation and fixed with 
4% paraformaldehyde for immunocytochemistry.
Seahorse analysis. Kidney organoids at day 16 of differentiation were resuspended 
in warm Seahorse XF Assay Medium (Seahorse Bioscience). Individual organoids 
were transferred to an islet plate (one organoid per well) containing 400 µ l of 
medium per well. After 1 h of incubation at 37 °C, plates were loaded into an XF24 
respirometry machine (Seahorse Bioscience). Uncoupled and maximum OCR were 
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assayed with oligomycin (1 µ M) and FCCP (1.5 µ M). To inhibit complex I- and 
III-dependent respiration, rotenone (1 µ M) and antimycin A (1 µ M) were used, 
respectively. OCR represents the oxygen tension and acidification of the medium 
as a function of time (pmol min−1).
Implantation of kidney organoids onto chick CAM. Following animal care 
guidelines in Spain, no approval was required to perform the experiments 
described here. Briefly, fertilized white Leghorn chicken eggs were supplied by 
Granja Gibert. Eggs were placed horizontally in a humidified atmosphere at 38 °C 
in a Javier Masalles 240 N incubator. After 24 h, 3 ml of albumin was evacuated 
from the egg using a 18-gauge syringe. At embryonic day 7 (ED 7), a small window 
was created by cutting the egg shell using a sterile scalpel. Then, day 16 kidney 
organoids were implanted onto the surface of the CAM (one kidney organoid per 
egg) by gently scraping the upper CAM layer (avoiding bleeding or visible rupture 
of capillaries) at the desired implantation site. Egg windows were sealed with 
conventional plastic tape and incubated for 3–5 additional days (until ED 10–12).
Intravital imaging of the CAM vasculature. Under a dissecting microscope, 
superficial CAM veins were injected with 1 mg ml−1 FITC–dextran (2 MDa) (FD-
2000S, Sigma) in PBS using a 30-gauge Hamilton syringe, allowing solutions 
to circulate for 5 min. Injected volumes were kept at 50 µ l. Live imaging was 
performed using a MZ10 F Leica stereomicroscope equipped with a MC170 HD 
Leica camera.
Nephrotoxicity assay. Chick embryos (ED 14) that contained kidney organoids 
implanted into the CAM were intravenously injected with desired dosages 
of cisplatin (P4394, Sigma) using a 30-gauge Hamilton syringe, as previously 
reported34. Specimens injected with control solution (without cisplatin) were used 
as controls. Eggs were then sealed with conventional plastic tape and incubated 
overnight at 38 °C. After 24 h, CAM-implanted kidney organoids were collected 
and analysed.
Histological analysis and immunohistochemistry on CAM-implanted kidney 
organoids. CAM-implanted kidney organoids were harvested at day 5 of the 
implantation period, fixed in 4% paraformaldehyde at 4 °C overnight and 
embedded in paraffin. For histological analysis, 5 µ m thick sections were stained 
with haematoxylin and eosin. For immunohistochemistry, antigen retrieval 
consisting of citrate buffer (pH 6) at 95 °C for 30 min was performed. Samples were 
then blocked with TBS containing 3% donkey serum and 1% Triton X-100 for 1 h 
at room temperature. Subsequently, primary antibodies were used overnight at 
4 °C in TBS with 3% donkey serum and 0.5% Triton X-100. After three washing 
steps with TBS containing 3% donkey serum and 0.5% Triton X-100, samples were 
treated with the appropriate conjugated secondary antibodies (Alexa Fluor 488-, 
Cy3- or A647-; all 1:200) for 2 h at room temperature. Nuclei were stained with 
DAPI (1:5000, D1306, Life Technologies) for 10 min. Samples were immersed in 
Fluoromount-G (0100-01, Southern Biotech). Image acquisition was carried out 
using a SP5 Leica microscope or a Zeiss LSM780 confocal microscope. Primary 
antibodies and associated information are provided in Supplementary Table 5.
Determination of the Young’s modulus of the chick CAM. The ball indentation 
method was used to assess the Young’s modulus (E) of the chick CAM, as described 
in ref. 35. The indentation depth (d) was calculated based on the derivative 
of fluorescence intensity profile using a custom-made MATLAB code. E was 
calculated from the indentation force (F), d and the radius of the ball indentor (R). 
For d < 0.3 R, the Hertz contact mechanics model was used to calculate E as follows: 
E = [3(1 − 2)F]/4R0.5d1.5, where  ν is the Poisson’s ratio of the CAM.
Fabrication of functionalized polyacrylamide hydrogels. Glass-bottom 
dishes were loaded with a solution of acetic acid, 3-(trimethoxysilyl)propyl 
methacrylate (Sigma) and ethanol (1/1/14). Wells were next rinsed three times 
with 96% ethanol. Different concentrations of acrylamide and bis-acrylamide 
were combined with a solution containing 0.5% ammonium persulfate, 0.05% 
tetramethylethylenediamine (Sigma) and 2% fluorescent 200 nm far-red 
carboxylated nanobeads (Invitrogen). Specifically, concentrations of 5 and 0.04% 
of acrylamide and bis-acrylamide were used for the softer hydrogels, and 12% 
and 0.25% of acrylamide and bis-acrylamide for the stiffer hydrogels, resulting 
in a nominal Young’s modulus of 1 kPa and 60 kPa, respectively, according to ref. 
36. The substrates were functionalized as previously described in ref. 37. Briefly, a 
drop containing 1 mg ml−1 acrylic acid NHS (A8060, Sigma), 0.2% bis-acrylamide, 
0.2% tetramethacrylate (408360, Sigma) and 0.05% (w/v) Irgacure 2959 was added 
on the surface of the hydrogel and photoactivated under exposure to ultraviolet 
light for 10 min. Afterwards, functionalized hydrogels were washed with HEPES 
and PBS and incubated overnight with 50 µ g ml−1 vitronectin (A14700, Fisher 
Scientific) at 4 °C.
Quantification of immunofluorescence images. A custom-made MATLAB 
code was used to perform the quantification of immunofluorescence images. For 
quantification of number and area of RVs, the DAPI image was first smoothed 
with a mean filter to homogenize the intensity values of the nuclei within an RV. 
This image was converted into a binary image after applying an intensity threshold. 
The binary image was used to segment the RVs by applying a watershed algorithm. 
From this segmentation, a list containing the area of each RV and the number of 
RVs was obtained. The entire area of the organoid was identified using the same 
principle but reducing the threshold for the binary conversion. The percentage 
of area occupied by RVs was calculated by adding the area of all RVs identified 
divided by the entire area of the organoid. For quantification of LTL+ and PODXL+ 
structures, the percentage of area occupied by LTL+ and PODXL+ structures was 
calculated using the same procedure as described above. For quantification of 
WT1+ cells, the DAPI image was converted into a binary image after applying an 
intensity threshold. The binary image was used to segment the nuclei by applying a 
watershed algorithm. All nuclei found were counted. The same procedure was used 
to identify WT1+ nuclei. The positive nuclei in WT1 images were divided by the 
number of DAPI nuclei, giving a percentage of WT1+ cells for each condition.
Human kidney material. Primary human proximal tubular cells were obtained 
from collaborators at Hospital Clinic de Barcelona, Spain. The procedure was 
approved by the ethics committee of Hospital Clinic de Barcelona (project no. 
2009/5023). Primary renal proximal tubular epithelial cells were obtained in 
the laboratory of origin as previously described38. Human fetal kidney samples 
included in this study were provided by the Fetal Tissue Bank of Vall d’Hebron 
University Hospital Biobank (PT13/0010/0021), part of the Spanish National 
Biobanks Network, and they were processed following standard operating 
procedures with the appropriate approval of the Ethical and Scientific Committees 
(project no. 0336E/9934/2015). The gestational age of human fetal kidney samples 
was determined using ultrasound heel-to-toe and crown-to-rump measurements39. 
Human fetal kidney samples from 13, 16 and 22 weeks of gestation were supplied 
as whole tissues embedded in OCT (at − 80 °C) and as frozen tissue samples for 
RNA extraction.
Statistics and reproducibility. Data are mean ± standard deviation (s.d.). 
Statistical differences between two groups were tested with a two-tailed Student’s 
t-test or one-way analysis of variance followed by Tukey’s post hoc test. Data 
were statistically significant if P < 0.05. Number of replicates (n = x), P values and 
degrees of freedom are included in the figure legends. GraphPad Prism version 
6.01 software was used for statistical analysis. A table summarizing sample size, 
number of experiments and statistical test results (when applicable) for each figure 
panel is also provided as Supplementary Table 7.
For in vitro experiments, two to six organoids were analysed at the times and 
conditions indicated in each experiment. For ex vivo reaggregation assay, we used 
one to three pregnant mice (to collect embryonic kidneys from mouse embryos) 
per experiment. Two or three reaggregates were analysed per experiment. For 
implantation of organoids into chick CAM in ovo, about 6–22 chicken eggs were 
used per experiment and about 2–10 implanted kidney organoids were analysed 
per experiment.
RNA-Seq of kidney organoids during the time course differentiation was 
performed on six pooled kidney organoids at each time analysed from two 
independent experiments (Fig. 1c and Supplementary Fig. 9).
For main figures where representative immunofluorescence images are shown, 
at least n = 2 biologically independent kidney organoids were analysed from 
independent experiments showing similar results (Fig. 1b, n = 2 organoids; Fig. 2g, 
n = 3 organoids per treatment; Fig. 2m, n = 4 organoids per culture condition; 
Fig. 3l,m, n = 2 implanted organoids; Fig. 3n, n = 3 implanted organoids; Fig. 4a, 
n = 2 organoids per stiffness condition; Fig. 4c, n = 3 organoids per stiffness 
condition).
For main figures where representative TEM images are shown, n = 2 
biologically independent kidney organoids were analysed from independent 
experiments showing similar results (Fig. 1e–j, Fig. 3e–k, Fig. 4f–i and Fig. 4k–n).
Macroscopic images of kidney organoids after implantation into chick CAM 
are representative of three independent CAM implantation experiments (Fig. 3b, 
n = 6 implanted organoids; Fig. 3c, n = 10 implanted organoids; Fig. 3d, n = 3 
implanted organoids after dextran–FITC injection).
For supplementary figures, complete information on the number of 
independent experiments and samples analysed is provided in the corresponding 
figure legends.
Reporting Summary. Further information on research design is available in 
the Nature Research Reporting Summary linked to this article.
Code availability
MATLAB codes can be requested from the corresponding author.
Data availability
RNA-Seq data are publicly available in Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo) under the accession numbers GSE108349, GSE108350 
and GSE108351. All remaining datasets supporting the findings described here are 
available within the article and its supplementary information files. Additionally, 
data are available from the corresponding author upon reasonable request.
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Antibodies used Antibodies and other staining reagents used for immunocytochemistry/immunohistochemistry:  
OCT4 (Santa Cruz, Cat# sc-5279, clone C-10, Lot# L2216, Dilution 1:25);  
Nanog (R&D Systems, Cat# A F1997, polyclonal, Lot# KKJ0616121, Dilution 1:25);  
YAP (Santa Cruz, Cat# sc-101199, clone 63.7, Lot# I0315, Dilution 1:200);  
Brachyury (R&D Systems, Cat# AF2085, polyclonal, Lot# KQP031611, Dilution 1:100);  
PAX2 (R&D Systems, Cat# AF3364, polyclonal, Lot# XOT0215072, Dilution 1:20);  
SALL1 (R&D Systems, Cat# PP-K9814-00, clone K9814, Lot# A-3, Dilution 1:100);  
WT1 (Abcam, Cat# ab89901, clone CAN-R9(IHC)-56-2, Lot# GR177328-54, Dilution 1:100);  
OSR1 (Abnova, Cat# H00130497-M04, clone 3F3, Lot# DB041-3F3, Dilution 1:25);  
LHX1 (Developmental Studies Hybridoma Bank, Cat# 4F2-s, clone 4F2, Dilution 1:50);  
SIX2 (Proteintech, Cat# 11562-1-AP, polyclonal, Dilution  1:500);  
PAX8 (Proteintech, Cat# 10336-1-AP, polyclonal, Dilution 1:500);  
ECAD (BD Bioscience, Cat# 610181, clone 36/E-cadherine, Lot# 7187865, Dilution 1:50);  
PODXL (R&D Systems, Cat# BAF1658, polyclonal, Lot# JLV0112111, Dilution 1:25);  
HNF1β (Santa Cruz, Cat# sc-7411, clone C-20, Lot# B0116, Dilution 1:100);  
BRN1 (Santa Cruz, Cat# sc-6028-R, clone C-17, Lot# J2512, Dilution 1:200);  
NEPHRIN (R&D Systems, Cat# AF4269, polyclonal, Lot# ZMU0114031, Dilution 1:300);  
KIM1 (R&D Systems, Cat# AF1750, polyclonal, Lot# JTB0317031, Dilution 1:300);  
cleaved Caspase-3 (Cell Signalling, Cat# 9661S, clone D175, Lot# 45, Dilution 1:200);  
CD34 (Abcam, Cat# ab8536, cloneQBEND-10, Lot# GR49632-21, Dilution 1:200);  
CD31 (Abcam, Cat# ab28364, polyclonal, Lot# GR31176844-16, Dilution 1:50);  
HuNu (Abcam, Cat# ab191181, clone 235-1, Lot# GR3185051-2, Dilution 1:100);  
Uromodulin (UMOD) (R&D Systems, Cat# AF5144, polyclonal, Lot# CBRF0114081, Dilution 1:50);  
Aquaporin 1 (AQP1) (Santa Cruz, Cat# sc-20810, clone H-55, Lot# C1815, Dilution 1:50);  
SLC3A1 (Sigma, Cat# HPA038360, polyclonal, Lot# R35388, Dilution 1:100);  
Laminin (Sigma, Cat# L9393, polyclonal, Lot# 028M4890V, Dilution 1:50);  
PODOCIN (Sigma, Cat# P0372, polyclonal, Lot# 064M4780, Dilution 1:50);  
NEPH1 (Santa Cruz, Cat# sc-373787, clone F-6, Lot# A0313, Dilution 1:50);  
SGLT2 (Abcam, Cat# ab37296, polyclonal, Lot# GR320725-7, Dilution 1:100);  
Sodium potassium ATPase (NaK) (Abcam, Cat# ab209299, clone ED1845Y, Lot# GRZ64184-1, Dilution 1:200);  
Biotinylated Lotus Tetragonolobus Lectin (LTL) (Vector Laboratories, Cat# B-1325, Lot# ZC2428, Dilution 1:200);  
Biotinylated Lens Culinaris Agglutinin (LCA) (Vector Laboratories, Cat# B-1045, Lot# ZC1221, Dilution 1:500);  
Alexa Fluor 488-conjugated streptavidin (Vector Laboratories, Cat# SA5488, Lot# ZD0313, Dilution: 1:50); 
 
Antibodies and other staining reagents used for flow cytometry: 
Fluorescein labeled LTL (Vector Laboratories, Cat# FL-1321, Lot# ZC0914, Dilution: 1:500);  
OCT4 conjugated to Alexa Fluor-488 (BD Pharmigen, Cat# 560253, Lot# 7110598, Dilution: 20 μl/test);  
Alexa Fluor 488 Mouse IgG1k isotype control (BD Pharmigen, Cat# 557721, Lot# 7082749, Dilution: 5 μl/test); 
Brachyury conjugated to allophycocyanin (APC) (R&D Systems, Cat# IC2085A, Lot# ADUQ0216041, Dilution: 10 μl/test); 
Goat IgG APC-conjugated antibody (R&D Systems, Cat# IC108A, Lot# AAOE0516031, Dilution: 10 μl/test); 
PAX2 conjugated to A488 using the Lightning-Link® Rapid conjugation kit (322-0010, Innova Biosciences) (R&D Systems, Cat# 
AF3364, Lot# XOT0215072, Dilution: 1:200); 
Normal Goat IgG Alexa Fluor® 488-conjugated Control (R&D Systems, Cat# IC108G, Lot# ABWO41607, Dilution: 5 μl/test); 
LIVE/DEAD Fixable Violet stain reagent (Life Technologies, Cat# L23105, Dilution: 1:1000) 
 
Information of all antibodies / staining reagents is provided in the Methods section or Supplementary information of the 
manuscript. 
Validation Antibody validations for the species and assay used were performed by antibody suppliers as described in the manufacture's 
web page, or were published in previous studies. Relevant articles are: 
 
Xia Y, Nivet E, Sancho-Martinez I, Gallegos T, Suzuki K, Okamura D, Wu MZ, Dubova I, Esteban CR, Montserrat N, Campistol JM, 
Izpisua Belmonte JC. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat Cell Biol. 
2013 Dec;15(12):1507-15. doi: 10.1038/ncb2872. Epub 2013 Nov 17. PubMed PMID: 24240476. (OCT4, OSR1, SIX2: human, 
immunofluorescence).  
 
Martí M, Mulero L, Pardo C, Morera C, Carrió M, Laricchia-Robbio L, Esteban CR, Izpisua Belmonte JC. Characterization of 
pluripotent stem cells. Nat Protoc. 2013 Feb;8(2):223-53. doi: 10.1038/nprot.2012.154. Epub 2013 Jan 10. PubMed PMID: 
23306458. (OCT4, Nanog, Brachyury: human, immunofluorescence).  
 
Elosegui-Artola A, Andreu I, Beedle AEM, Lezamiz A, Uroz M, Kosmalska AJ, Oria R, Kechagia JZ, Rico-Lastres P, Le Roux AL, 
Shanahan CM, Trepat X, Navajas D, Garcia-Manyes S, Roca-Cusachs P. Force Triggers YAP Nuclear Entry by Regulating Transport 
across Nuclear Pores. Cell. 2017 Nov 30;171(6):1397-1410.e14. doi: 10.1016/j.cell.2017.10.008. Epub 2017 Oct 26. PubMed 
PMID: 29107331. (YAP: human, immunofluorescence) 
 
Morizane R, Lam AQ, Freedman BS, Kishi S, Valerius MT, Bonventre JV. Nephron organoids derived from human pluripotent stem 
cells model kidney development and injury. Nat Biotechnol. 2015 Nov;33(11):1193-200. PubMed PMID: 26458176; PubMed 
Central PMCID: PMC4747858. (SALL1, LHX1, SIX2, PAX8, PODXL, HNF1β, BRN1, KIM1, LTL: human, immunofluorescence) 
 
Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C, Parton RG, Wolvetang EJ, Roost MS, Chuva de Sousa Lopes SM, Little 
MH. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015 Oct 
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22;526(7574):564-8. doi: 10.1038/nature15695. Epub 2015 Oct 7. Erratum in: Nature. 2016 Aug 11;536(7615):238. PubMed 
PMID: 26444236. (SIX2, ECAD, NEPHRIN, Caspase-3, LTL: human, immunofluorescence). 
 
Sharmin S, Taguchi A, Kaku Y, Yoshimura Y, Ohmori T, Sakuma T, Mukoyama M, Yamamoto T, Kurihara H, Nishinakamura R. 
Human Induced Pluripotent Stem Cell-Derived Podocytes Mature into Vascularized Glomeruli upon Experimental 
Transplantation. J Am Soc Nephrol. 2016 Jun;27(6):1778-91. doi: 10.1681/ASN.2015010096. Epub 2015 Nov 19. PubMed PMID: 
26586691; PubMed Central PMCID: PMC4884101. (CD31: human, immunofluorescence). 
 
Cai G, Lai B, Hong H, Lin P, Chen W, Zhu Z, Chen H. Effects of cryopreservation on excretory function, cellular adhesion molecules 
and vessel lumen formation in human umbilical vein endothelial cells. Mol Med Rep. 2017 Jul;16(1):547-552. doi: 10.3892/
mmr.2017.6664. Epub 2017 May 31. PubMed PMID:28586042; PubMed Central PMCID: PMC5482135. (CD34: human, 
immunofluorescence). 
 
Lei P, Ding D, Xie J, Wang L, Liao Q, Hu Y. Expression profile of Twist, vascular endothelial growth factor and CD34 in patients with 
different phases of osteosarcoma. Oncol Lett. 2015 Jul;10(1):417-421. Epub 2015 May 20. PubMed PMID: 26171042; PubMed 
Central PMCID: PMC4487166. (CD34: human, immunofluorescence). 
 
Cruz NM, Song X, Czerniecki SM, Gulieva RE, Churchill AJ, Kim YK, Winston K, Tran LM, Diaz MA, Fu H, Finn LS, Pei Y, Himmelfarb 
J, Freedman BS. Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease. Nat 
Mater. 2017 Nov;16(11):1112-1119. doi: 10.1038/nmat4994. Epub 2017 Oct 2. PubMed PMID: 28967916; PubMed Central 
PMCID: PMC5936694. (NEPHRIN, PODXL, LTL, Fluorescein labeled LTL: human, immunofluorescence). 
 
Lindström NO, Tran T, Guo J, Rutledge E, Parvez RK, Thornton ME, Grubbs B, McMahon JA, McMahon AP. Conserved and 
Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. J Am Soc Nephrol. 2018 
Mar;29(3):825-840. doi: 10.1681/ASN.2017091036. Epub 2018 Feb 15. PubMed PMID: 29449451; PubMed Central PMCID: 
PMC5827611. (Pax2, WT1, SLC3A1, Uromodulin: human, immunofluorescence). 
 
Vedula EM, Alonso JL, Arnaout MA, Charest JL. A microfluidic renal proximal tubule with active reabsorptive function. PLoS One. 
2017 Oct 11;12(10): e0184330. doi: 10.1371/journal.pone.0184330. eCollection 2017. PubMed PMID: 29020011; PubMed 
Central PMCID: PMC5636065. (SGLT2: human, immunofluorescence). 
 
Kang KJ, Lee MS, Moon CW, Lee JH, Yang HS, Jang YJ. In Vitro and In Vivo Dentinogenic Efficacy of Human Dental Pulp-Derived 
Cells Induced by Demineralized Dentin Matrix and HA-TCP. Stem Cells Int. 2017; 2017:2416254. doi:10.1155/2017/2416254. 
Epub 2017 Jun 28. PubMed PMID: 28761445; PubMed Central PMCID: PMC5518496. (HuNu: human, immunofluorescence). 
 
Jilani SM, Murphy TJ, Thai SN, Eichmann A, Alva JA, Iruela-Arispe ML. Selective binding of lectins to embryonic chicken 
vasculature. J Histochem Cytochem. 2003 May;51(5):597-604. PubMed PMID: 12704207. (Biotinylated Lens Culinaris Agglutinin: 
chicken, immunofluorescence). 
 
Yamaguchi S, Morizane R, Homma K, Monkawa T, Suzuki S, Fujii S, Koda M, Hiratsuka K, Yamashita M, Yoshida T, Wakino S, 
Hayashi K, Sasaki J, Hori S, Itoh H. Generation of kidney tubular organoids from human pluripotent stem cells. Sci Rep. 2016 Dec 
16;6: 38353. doi: 10.1038/srep38353.PubMed PMID: 27982115; PubMed Central PMCID: PMC5159864. (Aquaporin 1: human, 
immunofluorescence). 
 
Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, 
Asplund A, Sjöstedt E, Lundberg E, Szigyarto CA, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, Nilsson P, Schwenk JM, 
Lindskog C, Danielsson F, Mardinoglu A, Sivertsson A, von Feilitzen K, Forsberg M, Zwahlen M, Olsson I, Navani S, Huss M, Nielsen 
J, Ponten F, Uhlén M. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and 
antibody-based proteomics. Mol Cell Proteomics. 2014 Feb;13(2):397-406. doi: 10.1074/mcp.M113.035600. Epub 2013 Dec 5. 
PubMed PMID: 24309898; PubMed Central PMCID: PMC3916642. (PODOCIN: human, immunofluorescence). 
 
Wong KG, Ryan SD, Ramnarine K, Rosen SA, Mann SE, Kulick A, De Stanchina E,Müller FJ, Kacmarczyk TJ, Zhang C, Betel D, 
Tomishima MJ. CryoPause: A New Method to Immediately Initiate Experiments after Cryopreservation of Pluripotent Stem Cells. 
Stem Cell Reports. 2017 Jul 11;9(1):355-365. doi: 10.1016/j.stemcr.2017.05.010. Epub 2017 Jun 8. PubMed PMID: 28602613; 
PubMed Central PMCID: PMC5511100. (Brachyury conjugated to allophycocyanin (APC): human, flow cytometry). 
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) Human pluripotent stem cell lines: 
All the human pluripotent stem cell lines used in this study were obtained after the approval of the Ethics Committee of the 
CMRB and the approval of the Comisión de Seguimiento y Control de la Donación de Células y Tejidos Humanos del Instituto 
de Salud Carlos III (project numbers: 0336E/7564/2016; 0336E/5311/2015; 0336E/15986/2016; 0336E/79489/2015; 
00336E/20031/2014). ES[4] hESC and CBiPSsv-4F-40 were obtained from The National Bank of Stem Cells (ISCIII, Madrid). H1 
and H9 hESC lines were purchased at Wicell.  
Information on cell line sources used in this study is also provided in the Methods section of the manuscript.  
 
Human kidney material: 
Primary human proximal tubular cells were obtained from collaborators at Hospital Clinic de Barcelona, Spain. The ethics 
committee of Hospital Clinic de Barcelona approved the procedure, and signed consent forms are available upon request 
(project number: 2009/5023). Isolation of primary renal proximal tubular epithelial cells was performed as previously 
described. Briefly, tubular cells were prepared from renal tissue after nephrectomy. Cortical renal tissue was digested in 
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Iscove's modified Dulbecco's medium with 1% collagenase IV (Invitrogen) for 1h under shaking. Cell suspension was placed 
on a pre-cooled Percoll density gradient solution (Amersham Biosciences) and centrifuged for 40 min at 4 °C at 16,000 rpm 
(gradient with densities between 1.019 and 1.139 g/ml was generated). The cell fraction between 1.05 and 1.076 g/ml was 
collected and cells were plated on plastic plates with DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS; 
Invitrogen), Glutamax (1 mM), penicillin/streptomycin, and nonessential amino acids (100 μM). 
Relevant reference:  
Montserrat N, Ramírez-Bajo MJ, Xia Y, Sancho-Martinez I, Moya-Rull D, Miquel-Serra L, Yang S, Nivet E, Cortina C, González F, 
Izpisua Belmonte JC, Campistol JM. Generation of induced pluripotent stem cells from human renal proximal tubular cells 
with only two transcription factors, OCT4 and SOX2. J Biol Chem. 2012 Jul 13;287(29):24131-8. 
 
Human fetal kidney samples included in this study were provided by the Fetal Tissue Bank of Vall d’Hebron University 
Hospital Biobank (PT13/0010/0021), integrated in the Spanish National Biobanks Network and they were processed following 
standard operating procedures with the appropriate approval of the Ethical and Scientific Committees (project number: 
0336E/9934/2015). Human fetal kidney samples from 13, 16 and 22 weeks of gestation were supplied as whole tissues 
embedded in OCT (at -80 ºC) and as frozen tissue samples for RNA extraction.  
 
Information on human kidney material used in this study is also provided in the Methods section of the manuscript. 
Authentication Human pluripotent stem cell lines: 
Human embryonic stem cells (ES4, H1 and H9 lines) and human induced pluripotent stem cells (CBiPSsv-4F-40 line) were 
authenticated in their lab of origin through the expression of pluripotency-associated markers. 
 
Human kidney material: 
Primary human proximal epithelial cells were authenticated in the lab of origin for the expression of specific proximal tubular 
cell markers, as previously reported.  
Relevant reference:  
Montserrat N, Ramírez-Bajo MJ, Xia Y, Sancho-Martinez I, Moya-Rull D, Miquel-Serra L, Yang S, Nivet E, Cortina C, González F, 
Izpisua Belmonte JC, Campistol JM. Generation of induced pluripotent stem cells from human renal proximal tubular cells 
with only two transcription factors, OCT4 and SOX2. J Biol Chem. 2012 Jul 13;287(29):24131-8. 
 
The gestational age of human fetal kidney samples was determined per guidelines specified by the American College of 
Obstetricians and Gynecologists using ultrasound heel-to-toe, and crown-to-rump measurements.  
Relevant reference:  
O’Rahilly R, Müller F: Developmental stages in human embryos: Revised and new measurements. Cells Tissues Organs 192: 
73–84, 2010.
Mycoplasma contamination All cell lines tested negative for mycoplasma contamination.
Commonly misidentified lines
(See ICLAC register)
No commonly misidentified cell lines were used.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals For mice experiments:  
Animal care and experiments were carried out according to protocols approved by the Ethics Committee on Animal Research of 
the University of Barcelona, Spain (protocol number: OB 391/18). Embryonic kidneys from 11.5-12.5 days post conception (d.p.c) 
were collected from time-mated pregnant C57BL/6J mice.  
 
For chicken experiments:  
According to animal care guidelines in Spain, no approval was necessary to perform the experiments described herein. Fertilized 
white Leghorn chicken eggs were provided by Granja Gibert, rambla Regueral, S/N, 43850 Cambrils, Spain. 
Wild animals The study does not involve wild animals.




The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Cells were dissociated using accumax (07921, Stem Cell Technologies) for 5 min at 37ºC and stained according to a standard 
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Sample preparation methodology described in the Methods section of the manuscript. 
Kidney organoids were stained according to a standard methodology described in the Methods section of the manuscript. Kidney 
organoids were then dissociated to single cells using accumax (07921, Stem Cell Technologies) for 15 min followed by 0.25% (wt/
vol) trypsin (25300-054, Life Technologies) for 15 min at 37ºC.
Instrument Sony SA3800 spectral cell analyzer (SONY) was used to acquire flow cytometry samples (Supplementary Fig.1b and 
Supplementary Fig.2b), whereas FACSAria Fusion instrument (BD Biosciences) was used for cell sorting experiments 
(Supplementary Fig. 5b).
Software SA3800 software version 2.0.4 (SONY) was used to acquire flow cytometry samples in the Sony SA3800 spectral cell analyzer 
(SONY), whereas FACSDiva software version 8.0.1 (BD Biosciencies) was used in the FACS Aria Fusion instrument (BD Biosciences) 
for cell sorting experiments. FlowJo software version 10 was used to analyze these data.
Cell population abundance The abundance of the relevant cell populations was based on the expression of specific nuclear and surface markers that were  
analyzed by immunofluorescence and quantitative RT-PCR.
Gating strategy Supplementary Fig. 1b: 
For assessment of OCT4 and T staining, cells were first gated on a SS-A versus FS-A plot, the polulation from which was then 
gated on the LIVE/DEAD negative population (LIVE/DEAD versus FS-A plot), the population from which was then analyzed on a 
plot of T-APC versus OCT4-A488. 
 
Supplementary Fig. 2b: 
For assessment of PAX2 staining, cells were first gated on a SSC-A versus FSC-A plot, the polulation from which was then gated 
on the LIVE/DEAD negative population (LIVE/DEAD versus FSC-A plot), the population from which was then analyzed on a plot of 
SSC-A versus PAX2-A488. 
 
Supplementary Fig. 5b: 
For fluorescence activated cell sorting of LTL-FITC positive and negative cell fractions, cells were first gated on a SSC-A versus 
FSC-A plot, the polulation from which was then gated on singlets (FSC-W versus FSC-A plot), the population from which was then 
gated on the LIVE/DEAD negative population (LIVE/DEAD versus FSC-A plot), the population from which was then analyzed on a 
plot of autofluorescence (AU) versus LTL-FITC.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
